These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18524069)

  • 1. Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).
    Harv Law Rev; 2008 Apr; 121(6):1685-92. PubMed ID: 18524069
    [No Abstract]   [Full Text] [Related]  

  • 2. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 3. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
    Puckett A
    SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
    [No Abstract]   [Full Text] [Related]  

  • 5. Expanding access to investigational drugs for treatment use: a policy analysis and legislative proposal.
    Winniford A
    Health Matrix Clevel; 2009; 19(1):205-46. PubMed ID: 19459546
    [No Abstract]   [Full Text] [Related]  

  • 6. A new era of unapproved drugs: the case of Abigail Alliance v Von Eschenbach.
    Jacobson PD; Parmet WE
    JAMA; 2007 Jan; 297(2):205-8. PubMed ID: 17213404
    [No Abstract]   [Full Text] [Related]  

  • 7. Abigail Alliance v. Von Eschenbach: restricting access to potentially lifesaving drugs singe 2007.
    Goodman AJ
    J Contemp Health Law Policy; 2008; 25(1):107-41. PubMed ID: 19137749
    [No Abstract]   [Full Text] [Related]  

  • 8. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 9. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criminal procedure--substantive due process--D.C. Circuit holds that the government may forcibly treat incompetent criminal defendants with antipsychotic medication to render them competent to stand trial. --United States v. Weston, 255 F.3d 873 (D.C. Cir. 2001), petition for cert. filed (U.S. Sept. 5, 2001) (No. 01-6161).
    Harv Law Rev; 2001 Dec; 115(2):737-43. PubMed ID: 11958231
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanded access to investigational drugs for treatment use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutional law -- free exercise clause -- Ninth Circuit rejects strict scrutiny for pharmacy dispensing requirement. -- Stormans, Inc. v. Selecky, 571 F.3d 960 (9th Cir. 2009).
    Harv Law Rev; 2009 Dec; 123(2):596-603. PubMed ID: 20196268
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care law--Medicaid--Third Circuit finds providers lack standing to enforce the Medicaid Act.--Pennsylvania Pharmacists Ass'n v. Houstoun, 283 F.3d 531 (3d Cir. 2002), cert. denied, 123 S.Ct. 100 (2002).
    Harv Law Rev; 2003 Jan; 116(3):969-76. PubMed ID: 12530442
    [No Abstract]   [Full Text] [Related]  

  • 14. The right of access of the medically underserved to health care services.
    Brandin PA
    J Leg Med; 1981 Sep; 2(3):297-345. PubMed ID: 6976402
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanding access to investigational new therapies.
    Cohen C; Shevitz A; Mayer K
    Prim Care; 1992 Mar; 19(1):87-96. PubMed ID: 1594704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
    Leonard EW
    J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial and unusual punishment: an argument in support of prisoner participation in clinical trials.
    Hoffman S
    Indiana Law Rev; 2000; 33(2):475-515. PubMed ID: 16189915
    [No Abstract]   [Full Text] [Related]  

  • 18. Practical, legal, and ethical issues in expanded access to investigational drugs.
    Darrow JJ; Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2015 Jan; 372(3):279-86. PubMed ID: 25587952
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanded access to Phase II clinical trials in oncology: a step toward increasing scientific validity and compassion.
    Marcee AK
    Food Drug Law J; 2008; 63(2):439-57. PubMed ID: 18561471
    [No Abstract]   [Full Text] [Related]  

  • 20. Minnesota's Right to Try law.
    Hermer LD
    Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.